Status:
COMPLETED
Nephrocalcinosis in Very Low Birth Weight Infants
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Infant; Premature, Light-For-Dates
Eligibility:
All Genders
Brief Summary
Extremely premature children benefit from specific follow-up that requires high nutritional intake and the use of specific therapies that expose them to the risk of nephrocalcinosis. Other identified ...
Eligibility Criteria
Inclusion
- Newborns with a gestational age \<= 32 weeks and/or birthweight \<=1500g
Exclusion
- Newborns with kidney malformation
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
265 Patients enrolled
Trial Details
Trial ID
NCT04860583
Start Date
January 1 2012
End Date
December 31 2020
Last Update
April 27 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.